Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Effectiveness and Tolerability of Brivaracetam by Number of Lifetime Antiseizure Medications in Adults with Focal Onset Seizures: Pooled Data From Two Real-world Studies

              Author:Martin, Melinda S.   Bourikas, Dimitrios   Brock, Fiona   Dongre, Prashant   Elmoufti, Sami   Leunikava, Iryna   Little, Allison   Schulz, Anne-Liv   

              Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P11.010  

              Author Institution:UCB Pharma, Smyrna, GA  UCB Pharma, Alimos, Greece  UCB Pharma, Slough, United Kingdom  UCB Pharma, Morrisville, NC  UCB Pharma, Monheim am Rhein, Germany  

              Treatment Outcomes During Brivaracetam Treatment by Seizure Freedom Status at Baseline: Post hoc Analysis of a Real-world, US Study

              Author:Dave, Hina   French, Jacqueline A.   Henninger, Heidi   Altalib, Hamada Hamid   Porter, Roger   Gelfand, Michael   Martin, Melinda S.   Dongre, Prashant   Elmoufti, Sami   Schulz, Anne-Liv   Dimova, Svetlana   Sperling, Michael R.   

              Session Name:P14: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 2  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P14.001  

              Author Institution:University of Texas Southwestern Medical Center, Dallas, TX  NYU Comprehensive Epilepsy Center, New York, NY  Maine Medical Center, Portland, ME  Yale School of Medicine, New Haven, CT  University of Pennsylvania, Philadelphia, PA  UCB Pharma, Smyrna, GA  UCB Pharma, Morrisville, NC  UCB Pharma, Monheim am Rhein, Germany  UCB Pharma, Brussels, Belgium  Thomas Jefferson University, Philadelphia, PA